Naqvi Rubina, Ahmad Ejaz, Akhtar Fazal, Naqvi Anwar, Rizvi Adib
Sindh Institute of Urology and Transplantation, Dow Medical College and Civil Hospital, Karachi, Pakistan.
Nephrol Dial Transplant. 2003 Sep;18(9):1820-3. doi: 10.1093/ndt/gfg260.
Malaria, a common health problem in certain parts of the world, has a considerable morbidity and mortality. This study reports its occurrence with a serious complication, acute renal failure (ARF), at a Third World tertiary care centre.
All registered patients with ARF who had history and clinical findings suggestive of malaria and had malarial parasites on peripheral blood smears were included in this study. The data on their modes of presentation, management and outcome have been analysed.
Between January 1990 and December 1999, a total of 2098 patients with ARF were seen at the centre. Of these, 124 (5.9%) developed ARF due to malaria (falciparum in 121 and vivax in three). The male:female ratio was 4:1 and 84 (68%) patients were oligo- or anuric on presentation. Mean serum creatinine on admission was 9.43 +/- 5.39 mg/dl and 99 (79.8%) patients required renal replacement therapy. Of the cohort, 32 (25.8%) died, most within 48 h of admission. Age, oliguria, central nervous system involvement and presence of disseminated intravascular coagulopathy emerged as bad prognostic factors in simple univariate analysis. Of the survivors, 77 (62%) had complete recovery of renal function, while 15 (12%) were progressing towards recovery when lost to follow-up. The number of dialysis sessions did not differ significantly between the oliguric and non-oliguric groups.
In patients who do not succumb early to ARF of severe malaria, treatment with antimalarials and dialysis brings about recovery of renal function.
疟疾是世界某些地区常见的健康问题,具有相当高的发病率和死亡率。本研究报告了在一家第三世界三级医疗中心出现的伴有严重并发症急性肾衰竭(ARF)的疟疾病例。
本研究纳入了所有有疟疾病史和临床表现提示疟疾且外周血涂片发现疟原虫的ARF登记患者。分析了他们的就诊方式、治疗和结局数据。
1990年1月至1999年12月期间,该中心共诊治了2098例ARF患者。其中,124例(5.9%)因疟疾导致ARF(恶性疟121例,间日疟3例)。男女比例为4:1,84例(68%)患者就诊时为少尿或无尿。入院时平均血清肌酐为9.43±5.39mg/dl,99例(79.8%)患者需要肾脏替代治疗。在该队列中,32例(25.8%)死亡,大多数在入院后48小时内死亡。在单因素分析中,年龄、少尿、中枢神经系统受累和弥散性血管内凝血的存在是不良预后因素。在幸存者中,77例(62%)肾功能完全恢复,而15例(12%)在失访时肾功能正在恢复。少尿组和非少尿组的透析次数无显著差异。
对于未因重症疟疾的ARF早期死亡的患者,抗疟药和透析治疗可使肾功能恢复。